nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—PDE5A—coronary artery disease	0.537	1	CbGaD
Avanafil—CYP3A4—Ticagrelor—coronary artery disease	0.0352	0.146	CbGbCtD
Avanafil—CYP3A4—Fenofibrate—coronary artery disease	0.0313	0.13	CbGbCtD
Avanafil—CYP3A4—Gemfibrozil—coronary artery disease	0.025	0.104	CbGbCtD
Avanafil—CYP3A4—Clopidogrel—coronary artery disease	0.0217	0.0904	CbGbCtD
Avanafil—CYP3A4—Eplerenone—coronary artery disease	0.0202	0.0841	CbGbCtD
Avanafil—CYP3A4—Enalapril—coronary artery disease	0.018	0.0749	CbGbCtD
Avanafil—CYP3A4—Ezetimibe—coronary artery disease	0.014	0.0583	CbGbCtD
Avanafil—CYP3A4—Rosuvastatin—coronary artery disease	0.014	0.0583	CbGbCtD
Avanafil—CYP3A4—Simvastatin—coronary artery disease	0.013	0.0542	CbGbCtD
Avanafil—CYP3A4—Pravastatin—coronary artery disease	0.0127	0.053	CbGbCtD
Avanafil—CYP3A4—Lovastatin—coronary artery disease	0.0127	0.053	CbGbCtD
Avanafil—CYP3A4—Atorvastatin—coronary artery disease	0.0116	0.0483	CbGbCtD
Avanafil—CYP3A4—Losartan—coronary artery disease	0.0106	0.0442	CbGbCtD
Avanafil—PDE5A—pulmonary artery—coronary artery disease	0.0105	0.48	CbGeAlD
Avanafil—PDE5A—artery—coronary artery disease	0.0039	0.178	CbGeAlD
Avanafil—PDE5A—endothelium—coronary artery disease	0.0033	0.15	CbGeAlD
Avanafil—PDE5A—heart—coronary artery disease	0.00144	0.0655	CbGeAlD
Avanafil—PDE5A—cardiovascular system—coronary artery disease	0.00136	0.0618	CbGeAlD
Avanafil—PDE5A—Platelet homeostasis—LRP8—coronary artery disease	0.00135	0.0381	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—GUCY1A3—coronary artery disease	0.00121	0.034	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—PDE3A—coronary artery disease	0.00108	0.0303	CbGpPWpGaD
Avanafil—PDE5A—blood—coronary artery disease	0.00107	0.0489	CbGeAlD
Avanafil—PDE5A—Platelet homeostasis—ATP2B1—coronary artery disease	0.000872	0.0246	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—SLC8A1—coronary artery disease	0.000805	0.0227	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—coronary artery disease	0.000756	0.0213	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—ATP2A2—coronary artery disease	0.000618	0.0174	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—coronary artery disease	0.000608	0.0171	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—APOB—coronary artery disease	0.000395	0.0111	CbGpPWpGaD
Avanafil—CYP3A4—Liver X Receptor Pathway—ABCG5—coronary artery disease	0.000391	0.011	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SELPLG—coronary artery disease	0.000357	0.0101	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—PPP2CA—coronary artery disease	0.000354	0.00997	CbGpPWpGaD
Avanafil—CYP3A4—blood—coronary artery disease	0.000334	0.0152	CbGeAlD
Avanafil—CYP3A4—Estrogen metabolism—SULT1E1—coronary artery disease	0.000326	0.00919	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F13A1—coronary artery disease	0.000318	0.00896	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—MAPK14—coronary artery disease	0.000308	0.00866	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—DGKZ—coronary artery disease	0.000303	0.00855	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—LRP8—coronary artery disease	0.000303	0.00855	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—NOS2—coronary artery disease	0.000294	0.0083	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—OLR1—coronary artery disease	0.000291	0.00819	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—LEFTY2—coronary artery disease	0.000291	0.00819	CbGpPWpGaD
Avanafil—CYP3A4—Tamoxifen metabolism—SULT1E1—coronary artery disease	0.000288	0.00812	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GUCY1A3—coronary artery disease	0.00027	0.00762	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SERPINF2—coronary artery disease	0.000254	0.00716	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ANGPT1—coronary artery disease	0.000254	0.00716	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TTN—coronary artery disease	0.000254	0.00716	CbGpPWpGaD
Avanafil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—coronary artery disease	0.000248	0.00699	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—SULT1A1—coronary artery disease	0.000244	0.00688	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PDE3A—coronary artery disease	0.000241	0.00679	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PF4—coronary artery disease	0.000241	0.00679	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GP1BA—coronary artery disease	0.000241	0.00679	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—GSTA1—coronary artery disease	0.000238	0.00672	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—NOS3—coronary artery disease	0.000237	0.00667	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SERPINC1—coronary artery disease	0.00023	0.00648	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITGA3—coronary artery disease	0.000225	0.00634	CbGpPWpGaD
Avanafil—CYP3A4—Tamoxifen metabolism—SULT1A1—coronary artery disease	0.000216	0.00608	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—coronary artery disease	0.000211	0.00595	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TEK—coronary artery disease	0.000205	0.00577	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PPBP—coronary artery disease	0.000205	0.00577	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—RAB5A—coronary artery disease	0.000205	0.00577	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITGA2B—coronary artery disease	0.000202	0.00568	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ATP2B1—coronary artery disease	0.000195	0.00551	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F3—coronary artery disease	0.000193	0.00543	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ANGPT2—coronary artery disease	0.000187	0.00528	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SELL—coronary artery disease	0.000187	0.00528	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SELP—coronary artery disease	0.000183	0.00515	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F5—coronary artery disease	0.000183	0.00515	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SLC8A1—coronary artery disease	0.00018	0.00508	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GATA4—coronary artery disease	0.000178	0.00502	CbGpPWpGaD
Avanafil—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000172	0.00485	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—P2RY12—coronary artery disease	0.000169	0.00475	CbGpPWpGaD
Avanafil—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000166	0.00467	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GNA12—coronary artery disease	0.000164	0.00462	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—THBD—coronary artery disease	0.000164	0.00462	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SELE—coronary artery disease	0.000155	0.00438	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000154	0.00434	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ALDOA—coronary artery disease	0.00015	0.00424	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.000147	0.00414	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CRK—coronary artery disease	0.00014	0.00395	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SH2B3—coronary artery disease	0.000138	0.0039	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—VWF—coronary artery disease	0.000138	0.0039	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ATP2A2—coronary artery disease	0.000138	0.0039	CbGpPWpGaD
Avanafil—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.000135	0.00381	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F7—coronary artery disease	0.000132	0.00372	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F2R—coronary artery disease	0.000132	0.00372	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SPARC—coronary artery disease	0.000132	0.00372	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IRF1—coronary artery disease	0.000129	0.00364	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—FGB—coronary artery disease	0.000129	0.00364	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TGFB2—coronary artery disease	0.000127	0.00357	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—THBS1—coronary artery disease	0.000126	0.00355	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	0.000123	0.00347	CbGpPWpGaD
Avanafil—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	0.00012	0.00339	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	0.000118	0.00333	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TIMP1—coronary artery disease	0.000118	0.00332	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PLAT—coronary artery disease	0.000118	0.00332	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	0.000116	0.00328	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITGAV—coronary artery disease	0.000104	0.00292	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—KNG1—coronary artery disease	0.000103	0.00291	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.000103	0.00289	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PLAUR—coronary artery disease	0.000102	0.00288	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IFNA2—coronary artery disease	0.000101	0.00285	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000101	0.00285	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PLG—coronary artery disease	0.0001	0.00282	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCE—coronary artery disease	9.62e-05	0.00271	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SOD1—coronary artery disease	9.59e-05	0.0027	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	9.07e-05	0.00256	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—APOB—coronary artery disease	8.85e-05	0.00249	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	8.76e-05	0.00247	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—HGF—coronary artery disease	8.61e-05	0.00242	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CSF2—coronary artery disease	8.51e-05	0.0024	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	8.31e-05	0.00234	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITGB3—coronary artery disease	8.16e-05	0.0023	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CD36—coronary artery disease	8.03e-05	0.00226	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	7.94e-05	0.00224	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PPP2CA—coronary artery disease	7.93e-05	0.00223	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	7.92e-05	0.00223	CbGpPWpGaD
Avanafil—Constipation—Captopril—coronary artery disease	7.88e-05	0.000475	CcSEcCtD
Avanafil—Dyspepsia—Perindopril—coronary artery disease	7.88e-05	0.000475	CcSEcCtD
Avanafil—Body temperature increased—Pravastatin—coronary artery disease	7.85e-05	0.000473	CcSEcCtD
Avanafil—Hypotension—Losartan—coronary artery disease	7.84e-05	0.000473	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	7.83e-05	0.00221	CbGpPWpGaD
Avanafil—Dizziness—Clopidogrel—coronary artery disease	7.82e-05	0.000471	CcSEcCtD
Avanafil—Palpitations—Ramipril—coronary artery disease	7.79e-05	0.00047	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PRKCD—coronary artery disease	7.78e-05	0.00219	CbGpPWpGaD
Avanafil—Pruritus—Simvastatin—coronary artery disease	7.77e-05	0.000469	CcSEcCtD
Avanafil—Dizziness—Lovastatin—coronary artery disease	7.77e-05	0.000468	CcSEcCtD
Avanafil—Vertigo—Timolol—coronary artery disease	7.74e-05	0.000467	CcSEcCtD
Avanafil—Back pain—Lisinopril—coronary artery disease	7.74e-05	0.000466	CcSEcCtD
Avanafil—Somnolence—Furosemide—coronary artery disease	7.73e-05	0.000466	CcSEcCtD
Avanafil—Gastrointestinal disorder—Perindopril—coronary artery disease	7.72e-05	0.000466	CcSEcCtD
Avanafil—Diarrhoea—Eplerenone—coronary artery disease	7.72e-05	0.000465	CcSEcCtD
Avanafil—Fatigue—Perindopril—coronary artery disease	7.71e-05	0.000465	CcSEcCtD
Avanafil—Cough—Ramipril—coronary artery disease	7.69e-05	0.000464	CcSEcCtD
Avanafil—Muscle spasms—Lisinopril—coronary artery disease	7.69e-05	0.000463	CcSEcCtD
Avanafil—Constipation—Perindopril—coronary artery disease	7.65e-05	0.000461	CcSEcCtD
Avanafil—Vomiting—Fenofibrate—coronary artery disease	7.65e-05	0.000461	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Losartan—coronary artery disease	7.65e-05	0.000461	CcSEcCtD
Avanafil—Body temperature increased—Trandolapril—coronary artery disease	7.63e-05	0.00046	CcSEcCtD
Avanafil—Dizziness—Ezetimibe—coronary artery disease	7.62e-05	0.000459	CcSEcCtD
Avanafil—Palpitations—Timolol—coronary artery disease	7.62e-05	0.000459	CcSEcCtD
Avanafil—Body temperature increased—Enalapril—coronary artery disease	7.6e-05	0.000458	CcSEcCtD
Avanafil—Insomnia—Losartan—coronary artery disease	7.59e-05	0.000458	CcSEcCtD
Avanafil—Rash—Fenofibrate—coronary artery disease	7.59e-05	0.000457	CcSEcCtD
Avanafil—Dermatitis—Fenofibrate—coronary artery disease	7.58e-05	0.000457	CcSEcCtD
Avanafil—Headache—Fenofibrate—coronary artery disease	7.54e-05	0.000454	CcSEcCtD
Avanafil—Vision blurred—Lisinopril—coronary artery disease	7.54e-05	0.000454	CcSEcCtD
Avanafil—Cough—Timolol—coronary artery disease	7.52e-05	0.000453	CcSEcCtD
Avanafil—Vomiting—Clopidogrel—coronary artery disease	7.52e-05	0.000453	CcSEcCtD
Avanafil—Diarrhoea—Simvastatin—coronary artery disease	7.52e-05	0.000453	CcSEcCtD
Avanafil—Gastrointestinal disorder—Furosemide—coronary artery disease	7.51e-05	0.000453	CcSEcCtD
Avanafil—Chest pain—Ramipril—coronary artery disease	7.51e-05	0.000453	CcSEcCtD
Avanafil—Myalgia—Ramipril—coronary artery disease	7.51e-05	0.000453	CcSEcCtD
Avanafil—Arthralgia—Ramipril—coronary artery disease	7.51e-05	0.000453	CcSEcCtD
Avanafil—Fatigue—Furosemide—coronary artery disease	7.5e-05	0.000452	CcSEcCtD
Avanafil—Body temperature increased—Telmisartan—coronary artery disease	7.49e-05	0.000452	CcSEcCtD
Avanafil—Vomiting—Lovastatin—coronary artery disease	7.47e-05	0.00045	CcSEcCtD
Avanafil—Somnolence—Losartan—coronary artery disease	7.46e-05	0.00045	CcSEcCtD
Avanafil—Dizziness—Eplerenone—coronary artery disease	7.46e-05	0.00045	CcSEcCtD
Avanafil—Rash—Clopidogrel—coronary artery disease	7.46e-05	0.00045	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.46e-05	0.000449	CcSEcCtD
Avanafil—Dermatitis—Clopidogrel—coronary artery disease	7.45e-05	0.000449	CcSEcCtD
Avanafil—Asthenia—Valsartan—coronary artery disease	7.45e-05	0.000449	CcSEcCtD
Avanafil—Hypertension—Timolol—coronary artery disease	7.44e-05	0.000449	CcSEcCtD
Avanafil—Constipation—Furosemide—coronary artery disease	7.44e-05	0.000448	CcSEcCtD
Avanafil—Asthenia—Olmesartan—coronary artery disease	7.41e-05	0.000447	CcSEcCtD
Avanafil—Headache—Clopidogrel—coronary artery disease	7.41e-05	0.000447	CcSEcCtD
Avanafil—Rash—Lovastatin—coronary artery disease	7.41e-05	0.000447	CcSEcCtD
Avanafil—Dermatitis—Lovastatin—coronary artery disease	7.4e-05	0.000446	CcSEcCtD
Avanafil—Dyspepsia—Losartan—coronary artery disease	7.39e-05	0.000445	CcSEcCtD
Avanafil—Headache—Lovastatin—coronary artery disease	7.36e-05	0.000444	CcSEcCtD
Avanafil—Pruritus—Valsartan—coronary artery disease	7.34e-05	0.000443	CcSEcCtD
Avanafil—Dry mouth—Ramipril—coronary artery disease	7.34e-05	0.000443	CcSEcCtD
Avanafil—Chest pain—Timolol—coronary artery disease	7.34e-05	0.000442	CcSEcCtD
Avanafil—Arthralgia—Timolol—coronary artery disease	7.34e-05	0.000442	CcSEcCtD
Avanafil—Myalgia—Timolol—coronary artery disease	7.34e-05	0.000442	CcSEcCtD
Avanafil—Vomiting—Ezetimibe—coronary artery disease	7.33e-05	0.000442	CcSEcCtD
Avanafil—PDE5A—Hemostasis—MMP1—coronary artery disease	7.32e-05	0.00206	CbGpPWpGaD
Avanafil—Pruritus—Olmesartan—coronary artery disease	7.31e-05	0.00044	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.29e-05	0.000439	CcSEcCtD
Avanafil—Body temperature increased—Captopril—coronary artery disease	7.29e-05	0.000439	CcSEcCtD
Avanafil—Dizziness—Simvastatin—coronary artery disease	7.27e-05	0.000438	CcSEcCtD
Avanafil—Rash—Ezetimibe—coronary artery disease	7.27e-05	0.000438	CcSEcCtD
Avanafil—Dermatitis—Ezetimibe—coronary artery disease	7.26e-05	0.000438	CcSEcCtD
Avanafil—Asthenia—Niacin—coronary artery disease	7.24e-05	0.000436	CcSEcCtD
Avanafil—Fatigue—Losartan—coronary artery disease	7.24e-05	0.000436	CcSEcCtD
Avanafil—Headache—Ezetimibe—coronary artery disease	7.22e-05	0.000435	CcSEcCtD
Avanafil—Vertigo—Lisinopril—coronary artery disease	7.18e-05	0.000433	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PLAU—coronary artery disease	7.18e-05	0.00202	CbGpPWpGaD
Avanafil—Dry mouth—Timolol—coronary artery disease	7.18e-05	0.000433	CcSEcCtD
Avanafil—Constipation—Losartan—coronary artery disease	7.18e-05	0.000433	CcSEcCtD
Avanafil—Vomiting—Eplerenone—coronary artery disease	7.17e-05	0.000432	CcSEcCtD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	7.15e-05	0.00201	CbGpPWpGaD
Avanafil—Nausea—Fenofibrate—coronary artery disease	7.15e-05	0.000431	CcSEcCtD
Avanafil—Pruritus—Niacin—coronary artery disease	7.14e-05	0.00043	CcSEcCtD
Avanafil—Asthenia—Pravastatin—coronary artery disease	7.13e-05	0.00043	CcSEcCtD
Avanafil—Rash—Eplerenone—coronary artery disease	7.11e-05	0.000429	CcSEcCtD
Avanafil—Dermatitis—Eplerenone—coronary artery disease	7.1e-05	0.000428	CcSEcCtD
Avanafil—Diarrhoea—Valsartan—coronary artery disease	7.1e-05	0.000428	CcSEcCtD
Avanafil—Body temperature increased—Perindopril—coronary artery disease	7.07e-05	0.000426	CcSEcCtD
Avanafil—Palpitations—Lisinopril—coronary artery disease	7.07e-05	0.000426	CcSEcCtD
Avanafil—Diarrhoea—Olmesartan—coronary artery disease	7.07e-05	0.000426	CcSEcCtD
Avanafil—Headache—Eplerenone—coronary artery disease	7.07e-05	0.000426	CcSEcCtD
Avanafil—Nervous system disorder—Ramipril—coronary artery disease	7.06e-05	0.000425	CcSEcCtD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	7.06e-05	0.00199	CbGpPWpGaD
Avanafil—Pruritus—Pravastatin—coronary artery disease	7.03e-05	0.000424	CcSEcCtD
Avanafil—Nausea—Clopidogrel—coronary artery disease	7.02e-05	0.000423	CcSEcCtD
Avanafil—Tachycardia—Ramipril—coronary artery disease	7.02e-05	0.000423	CcSEcCtD
Avanafil—PDE5A—Hemostasis—APOA1—coronary artery disease	7e-05	0.00197	CbGpPWpGaD
Avanafil—Skin disorder—Ramipril—coronary artery disease	6.99e-05	0.000421	CcSEcCtD
Avanafil—Infection—Timolol—coronary artery disease	6.99e-05	0.000421	CcSEcCtD
Avanafil—Vomiting—Simvastatin—coronary artery disease	6.99e-05	0.000421	CcSEcCtD
Avanafil—Cough—Lisinopril—coronary artery disease	6.98e-05	0.000421	CcSEcCtD
Avanafil—Nausea—Lovastatin—coronary artery disease	6.98e-05	0.000421	CcSEcCtD
Avanafil—Rash—Simvastatin—coronary artery disease	6.93e-05	0.000418	CcSEcCtD
Avanafil—Dermatitis—Simvastatin—coronary artery disease	6.92e-05	0.000417	CcSEcCtD
Avanafil—Asthenia—Trandolapril—coronary artery disease	6.92e-05	0.000417	CcSEcCtD
Avanafil—Diarrhoea—Niacin—coronary artery disease	6.9e-05	0.000416	CcSEcCtD
Avanafil—Nervous system disorder—Timolol—coronary artery disease	6.9e-05	0.000416	CcSEcCtD
Avanafil—Asthenia—Enalapril—coronary artery disease	6.89e-05	0.000416	CcSEcCtD
Avanafil—PDE5A—Hemostasis—MAPK14—coronary artery disease	6.89e-05	0.00194	CbGpPWpGaD
Avanafil—Headache—Simvastatin—coronary artery disease	6.88e-05	0.000415	CcSEcCtD
Avanafil—Body temperature increased—Furosemide—coronary artery disease	6.88e-05	0.000415	CcSEcCtD
Avanafil—Dizziness—Valsartan—coronary artery disease	6.86e-05	0.000414	CcSEcCtD
Avanafil—Nausea—Ezetimibe—coronary artery disease	6.84e-05	0.000413	CcSEcCtD
Avanafil—Skin disorder—Timolol—coronary artery disease	6.83e-05	0.000412	CcSEcCtD
Avanafil—Dizziness—Olmesartan—coronary artery disease	6.83e-05	0.000412	CcSEcCtD
Avanafil—Pruritus—Trandolapril—coronary artery disease	6.83e-05	0.000411	CcSEcCtD
Avanafil—Myalgia—Lisinopril—coronary artery disease	6.81e-05	0.00041	CcSEcCtD
Avanafil—Chest pain—Lisinopril—coronary artery disease	6.81e-05	0.00041	CcSEcCtD
Avanafil—Arthralgia—Lisinopril—coronary artery disease	6.81e-05	0.00041	CcSEcCtD
Avanafil—Asthenia—Telmisartan—coronary artery disease	6.8e-05	0.00041	CcSEcCtD
Avanafil—Pruritus—Enalapril—coronary artery disease	6.8e-05	0.00041	CcSEcCtD
Avanafil—Diarrhoea—Pravastatin—coronary artery disease	6.8e-05	0.00041	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.76e-05	0.000408	CcSEcCtD
Avanafil—Hypotension—Ramipril—coronary artery disease	6.72e-05	0.000405	CcSEcCtD
Avanafil—Pruritus—Telmisartan—coronary artery disease	6.71e-05	0.000404	CcSEcCtD
Avanafil—Nausea—Eplerenone—coronary artery disease	6.7e-05	0.000404	CcSEcCtD
Avanafil—PDE5A—Hemostasis—F2—coronary artery disease	6.68e-05	0.00188	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—FN1—coronary artery disease	6.68e-05	0.00188	CbGpPWpGaD
Avanafil—Dizziness—Niacin—coronary artery disease	6.67e-05	0.000402	CcSEcCtD
Avanafil—Dry mouth—Lisinopril—coronary artery disease	6.66e-05	0.000401	CcSEcCtD
Avanafil—Body temperature increased—Losartan—coronary artery disease	6.63e-05	0.0004	CcSEcCtD
Avanafil—Asthenia—Captopril—coronary artery disease	6.61e-05	0.000399	CcSEcCtD
Avanafil—Diarrhoea—Trandolapril—coronary artery disease	6.6e-05	0.000398	CcSEcCtD
Avanafil—Vomiting—Valsartan—coronary artery disease	6.6e-05	0.000398	CcSEcCtD
Avanafil—PDE5A—Hemostasis—NOS2—coronary artery disease	6.6e-05	0.00186	CbGpPWpGaD
Avanafil—Diarrhoea—Enalapril—coronary artery disease	6.57e-05	0.000396	CcSEcCtD
Avanafil—Hypotension—Timolol—coronary artery disease	6.57e-05	0.000396	CcSEcCtD
Avanafil—Dizziness—Pravastatin—coronary artery disease	6.57e-05	0.000396	CcSEcCtD
Avanafil—Vomiting—Olmesartan—coronary artery disease	6.57e-05	0.000396	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.56e-05	0.000395	CcSEcCtD
Avanafil—Rash—Valsartan—coronary artery disease	6.54e-05	0.000394	CcSEcCtD
Avanafil—Dermatitis—Valsartan—coronary artery disease	6.54e-05	0.000394	CcSEcCtD
Avanafil—Nausea—Simvastatin—coronary artery disease	6.53e-05	0.000393	CcSEcCtD
Avanafil—Pruritus—Captopril—coronary artery disease	6.52e-05	0.000393	CcSEcCtD
Avanafil—Rash—Olmesartan—coronary artery disease	6.51e-05	0.000393	CcSEcCtD
Avanafil—Insomnia—Ramipril—coronary artery disease	6.51e-05	0.000392	CcSEcCtD
Avanafil—Dermatitis—Olmesartan—coronary artery disease	6.51e-05	0.000392	CcSEcCtD
Avanafil—Headache—Valsartan—coronary artery disease	6.5e-05	0.000392	CcSEcCtD
Avanafil—Diarrhoea—Telmisartan—coronary artery disease	6.48e-05	0.000391	CcSEcCtD
Avanafil—Infection—Lisinopril—coronary artery disease	6.48e-05	0.000391	CcSEcCtD
Avanafil—Headache—Olmesartan—coronary artery disease	6.47e-05	0.00039	CcSEcCtD
Avanafil—Asthenia—Perindopril—coronary artery disease	6.42e-05	0.000387	CcSEcCtD
Avanafil—Vomiting—Niacin—coronary artery disease	6.42e-05	0.000387	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Timolol—coronary artery disease	6.41e-05	0.000386	CcSEcCtD
Avanafil—Somnolence—Ramipril—coronary artery disease	6.4e-05	0.000386	CcSEcCtD
Avanafil—Dizziness—Trandolapril—coronary artery disease	6.38e-05	0.000385	CcSEcCtD
Avanafil—Tachycardia—Lisinopril—coronary artery disease	6.37e-05	0.000384	CcSEcCtD
Avanafil—Insomnia—Timolol—coronary artery disease	6.36e-05	0.000384	CcSEcCtD
Avanafil—Rash—Niacin—coronary artery disease	6.36e-05	0.000384	CcSEcCtD
Avanafil—Dermatitis—Niacin—coronary artery disease	6.36e-05	0.000383	CcSEcCtD
Avanafil—Dizziness—Enalapril—coronary artery disease	6.35e-05	0.000383	CcSEcCtD
Avanafil—Skin disorder—Lisinopril—coronary artery disease	6.34e-05	0.000382	CcSEcCtD
Avanafil—Dyspepsia—Ramipril—coronary artery disease	6.33e-05	0.000382	CcSEcCtD
Avanafil—Pruritus—Perindopril—coronary artery disease	6.33e-05	0.000382	CcSEcCtD
Avanafil—Headache—Niacin—coronary artery disease	6.32e-05	0.000381	CcSEcCtD
Avanafil—Vomiting—Pravastatin—coronary artery disease	6.32e-05	0.000381	CcSEcCtD
Avanafil—Diarrhoea—Captopril—coronary artery disease	6.31e-05	0.00038	CcSEcCtD
Avanafil—Dizziness—Telmisartan—coronary artery disease	6.27e-05	0.000378	CcSEcCtD
Avanafil—Rash—Pravastatin—coronary artery disease	6.26e-05	0.000378	CcSEcCtD
Avanafil—Dermatitis—Pravastatin—coronary artery disease	6.26e-05	0.000377	CcSEcCtD
Avanafil—Somnolence—Timolol—coronary artery disease	6.25e-05	0.000377	CcSEcCtD
Avanafil—Asthenia—Furosemide—coronary artery disease	6.24e-05	0.000376	CcSEcCtD
Avanafil—Headache—Pravastatin—coronary artery disease	6.22e-05	0.000375	CcSEcCtD
Avanafil—Gastrointestinal disorder—Ramipril—coronary artery disease	6.21e-05	0.000375	CcSEcCtD
Avanafil—Fatigue—Ramipril—coronary artery disease	6.2e-05	0.000374	CcSEcCtD
Avanafil—Dyspepsia—Timolol—coronary artery disease	6.19e-05	0.000373	CcSEcCtD
Avanafil—Nausea—Valsartan—coronary artery disease	6.16e-05	0.000372	CcSEcCtD
Avanafil—Pruritus—Furosemide—coronary artery disease	6.15e-05	0.000371	CcSEcCtD
Avanafil—Constipation—Ramipril—coronary artery disease	6.15e-05	0.000371	CcSEcCtD
Avanafil—Nausea—Olmesartan—coronary artery disease	6.13e-05	0.00037	CcSEcCtD
Avanafil—Vomiting—Trandolapril—coronary artery disease	6.13e-05	0.00037	CcSEcCtD
Avanafil—Diarrhoea—Perindopril—coronary artery disease	6.12e-05	0.000369	CcSEcCtD
Avanafil—Vomiting—Enalapril—coronary artery disease	6.11e-05	0.000368	CcSEcCtD
Avanafil—Hypotension—Lisinopril—coronary artery disease	6.1e-05	0.000368	CcSEcCtD
Avanafil—Dizziness—Captopril—coronary artery disease	6.09e-05	0.000367	CcSEcCtD
Avanafil—Rash—Trandolapril—coronary artery disease	6.08e-05	0.000367	CcSEcCtD
Avanafil—Dermatitis—Trandolapril—coronary artery disease	6.08e-05	0.000366	CcSEcCtD
Avanafil—Gastrointestinal disorder—Timolol—coronary artery disease	6.07e-05	0.000366	CcSEcCtD
Avanafil—Fatigue—Timolol—coronary artery disease	6.07e-05	0.000366	CcSEcCtD
Avanafil—Rash—Enalapril—coronary artery disease	6.06e-05	0.000365	CcSEcCtD
Avanafil—Dermatitis—Enalapril—coronary artery disease	6.05e-05	0.000365	CcSEcCtD
Avanafil—Headache—Trandolapril—coronary artery disease	6.04e-05	0.000364	CcSEcCtD
Avanafil—Vomiting—Telmisartan—coronary artery disease	6.03e-05	0.000363	CcSEcCtD
Avanafil—Asthenia—Losartan—coronary artery disease	6.02e-05	0.000363	CcSEcCtD
Avanafil—Headache—Enalapril—coronary artery disease	6.02e-05	0.000363	CcSEcCtD
Avanafil—Nausea—Niacin—coronary artery disease	5.99e-05	0.000361	CcSEcCtD
Avanafil—Rash—Telmisartan—coronary artery disease	5.98e-05	0.00036	CcSEcCtD
Avanafil—Dermatitis—Telmisartan—coronary artery disease	5.97e-05	0.00036	CcSEcCtD
Avanafil—Diarrhoea—Furosemide—coronary artery disease	5.95e-05	0.000359	CcSEcCtD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	5.95e-05	0.00168	CbGpPWpGaD
Avanafil—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.95e-05	0.000358	CcSEcCtD
Avanafil—Pruritus—Losartan—coronary artery disease	5.94e-05	0.000358	CcSEcCtD
Avanafil—Headache—Telmisartan—coronary artery disease	5.94e-05	0.000358	CcSEcCtD
Avanafil—Dizziness—Perindopril—coronary artery disease	5.92e-05	0.000357	CcSEcCtD
Avanafil—Insomnia—Lisinopril—coronary artery disease	5.9e-05	0.000356	CcSEcCtD
Avanafil—Nausea—Pravastatin—coronary artery disease	5.9e-05	0.000356	CcSEcCtD
Avanafil—Vomiting—Captopril—coronary artery disease	5.86e-05	0.000353	CcSEcCtD
Avanafil—PDE5A—Hemostasis—IGF1—coronary artery disease	5.85e-05	0.00165	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	5.82e-05	0.00164	CbGpPWpGaD
Avanafil—Rash—Captopril—coronary artery disease	5.81e-05	0.00035	CcSEcCtD
Avanafil—Dermatitis—Captopril—coronary artery disease	5.81e-05	0.00035	CcSEcCtD
Avanafil—Somnolence—Lisinopril—coronary artery disease	5.8e-05	0.00035	CcSEcCtD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	5.8e-05	0.00163	CbGpPWpGaD
Avanafil—Headache—Captopril—coronary artery disease	5.77e-05	0.000348	CcSEcCtD
Avanafil—Dizziness—Furosemide—coronary artery disease	5.75e-05	0.000347	CcSEcCtD
Avanafil—Dyspepsia—Lisinopril—coronary artery disease	5.74e-05	0.000346	CcSEcCtD
Avanafil—Diarrhoea—Losartan—coronary artery disease	5.74e-05	0.000346	CcSEcCtD
Avanafil—Nausea—Trandolapril—coronary artery disease	5.73e-05	0.000345	CcSEcCtD
Avanafil—Nausea—Enalapril—coronary artery disease	5.71e-05	0.000344	CcSEcCtD
Avanafil—Vomiting—Perindopril—coronary artery disease	5.69e-05	0.000343	CcSEcCtD
Avanafil—Body temperature increased—Ramipril—coronary artery disease	5.69e-05	0.000343	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	5.65e-05	0.00159	CbGpPWpGaD
Avanafil—Rash—Perindopril—coronary artery disease	5.64e-05	0.00034	CcSEcCtD
Avanafil—Dermatitis—Perindopril—coronary artery disease	5.64e-05	0.00034	CcSEcCtD
Avanafil—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.63e-05	0.00034	CcSEcCtD
Avanafil—Nausea—Telmisartan—coronary artery disease	5.63e-05	0.000339	CcSEcCtD
Avanafil—Fatigue—Lisinopril—coronary artery disease	5.63e-05	0.000339	CcSEcCtD
Avanafil—Headache—Perindopril—coronary artery disease	5.61e-05	0.000338	CcSEcCtD
Avanafil—Constipation—Lisinopril—coronary artery disease	5.58e-05	0.000336	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	5.58e-05	0.00157	CbGpPWpGaD
Avanafil—Body temperature increased—Timolol—coronary artery disease	5.56e-05	0.000335	CcSEcCtD
Avanafil—PDE5A—Hemostasis—SERPINE1—coronary artery disease	5.56e-05	0.00157	CbGpPWpGaD
Avanafil—Dizziness—Losartan—coronary artery disease	5.55e-05	0.000335	CcSEcCtD
Avanafil—PDE5A—Hemostasis—ALB—coronary artery disease	5.55e-05	0.00156	CbGpPWpGaD
Avanafil—Vomiting—Furosemide—coronary artery disease	5.53e-05	0.000333	CcSEcCtD
Avanafil—Rash—Furosemide—coronary artery disease	5.48e-05	0.000331	CcSEcCtD
Avanafil—Dermatitis—Furosemide—coronary artery disease	5.48e-05	0.00033	CcSEcCtD
Avanafil—Nausea—Captopril—coronary artery disease	5.47e-05	0.00033	CcSEcCtD
Avanafil—Headache—Furosemide—coronary artery disease	5.45e-05	0.000329	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	5.36e-05	0.00151	CbGpPWpGaD
Avanafil—Vomiting—Losartan—coronary artery disease	5.34e-05	0.000322	CcSEcCtD
Avanafil—Nausea—Perindopril—coronary artery disease	5.31e-05	0.00032	CcSEcCtD
Avanafil—PDE5A—Hemostasis—NOS3—coronary artery disease	5.3e-05	0.00149	CbGpPWpGaD
Avanafil—Rash—Losartan—coronary artery disease	5.29e-05	0.000319	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	5.29e-05	0.00149	CbGpPWpGaD
Avanafil—Dermatitis—Losartan—coronary artery disease	5.29e-05	0.000319	CcSEcCtD
Avanafil—Headache—Losartan—coronary artery disease	5.26e-05	0.000317	CcSEcCtD
Avanafil—Nausea—Furosemide—coronary artery disease	5.17e-05	0.000311	CcSEcCtD
Avanafil—Asthenia—Ramipril—coronary artery disease	5.16e-05	0.000311	CcSEcCtD
Avanafil—Body temperature increased—Lisinopril—coronary artery disease	5.16e-05	0.000311	CcSEcCtD
Avanafil—PDE5A—Hemostasis—JAK2—coronary artery disease	5.16e-05	0.00145	CbGpPWpGaD
Avanafil—Pruritus—Ramipril—coronary artery disease	5.09e-05	0.000307	CcSEcCtD
Avanafil—Asthenia—Timolol—coronary artery disease	5.05e-05	0.000304	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	5.04e-05	0.00142	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	5.02e-05	0.00141	CbGpPWpGaD
Avanafil—Nausea—Losartan—coronary artery disease	4.99e-05	0.000301	CcSEcCtD
Avanafil—Pruritus—Timolol—coronary artery disease	4.98e-05	0.0003	CcSEcCtD
Avanafil—Diarrhoea—Ramipril—coronary artery disease	4.92e-05	0.000297	CcSEcCtD
Avanafil—Diarrhoea—Timolol—coronary artery disease	4.81e-05	0.00029	CcSEcCtD
Avanafil—Dizziness—Ramipril—coronary artery disease	4.76e-05	0.000287	CcSEcCtD
Avanafil—Asthenia—Lisinopril—coronary artery disease	4.68e-05	0.000282	CcSEcCtD
Avanafil—Dizziness—Timolol—coronary artery disease	4.65e-05	0.00028	CcSEcCtD
Avanafil—Pruritus—Lisinopril—coronary artery disease	4.62e-05	0.000278	CcSEcCtD
Avanafil—Vomiting—Ramipril—coronary artery disease	4.58e-05	0.000276	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—GCLM—coronary artery disease	4.56e-05	0.00128	CbGpPWpGaD
Avanafil—Rash—Ramipril—coronary artery disease	4.54e-05	0.000274	CcSEcCtD
Avanafil—Dermatitis—Ramipril—coronary artery disease	4.53e-05	0.000273	CcSEcCtD
Avanafil—Headache—Ramipril—coronary artery disease	4.51e-05	0.000272	CcSEcCtD
Avanafil—Vomiting—Timolol—coronary artery disease	4.47e-05	0.00027	CcSEcCtD
Avanafil—Diarrhoea—Lisinopril—coronary artery disease	4.47e-05	0.000269	CcSEcCtD
Avanafil—Rash—Timolol—coronary artery disease	4.44e-05	0.000267	CcSEcCtD
Avanafil—Dermatitis—Timolol—coronary artery disease	4.43e-05	0.000267	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	4.41e-05	0.00124	CbGpPWpGaD
Avanafil—Headache—Timolol—coronary artery disease	4.41e-05	0.000266	CcSEcCtD
Avanafil—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	4.35e-05	0.00123	CbGpPWpGaD
Avanafil—Dizziness—Lisinopril—coronary artery disease	4.32e-05	0.00026	CcSEcCtD
Avanafil—Nausea—Ramipril—coronary artery disease	4.27e-05	0.000258	CcSEcCtD
Avanafil—Nausea—Timolol—coronary artery disease	4.18e-05	0.000252	CcSEcCtD
Avanafil—Vomiting—Lisinopril—coronary artery disease	4.15e-05	0.00025	CcSEcCtD
Avanafil—Rash—Lisinopril—coronary artery disease	4.12e-05	0.000248	CcSEcCtD
Avanafil—Dermatitis—Lisinopril—coronary artery disease	4.11e-05	0.000248	CcSEcCtD
Avanafil—Headache—Lisinopril—coronary artery disease	4.09e-05	0.000246	CcSEcCtD
Avanafil—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	4.01e-05	0.00113	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	4.01e-05	0.00113	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	3.96e-05	0.00112	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	3.96e-05	0.00112	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	3.92e-05	0.0011	CbGpPWpGaD
Avanafil—Nausea—Lisinopril—coronary artery disease	3.88e-05	0.000234	CcSEcCtD
Avanafil—PDE5A—Hemostasis—VEGFA—coronary artery disease	3.82e-05	0.00108	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TGFB1—coronary artery disease	3.51e-05	0.000988	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—MAPK1—coronary artery disease	3.44e-05	0.000969	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	3.25e-05	0.000916	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	3.16e-05	0.00089	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	3.14e-05	0.000885	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	3.08e-05	0.000867	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	3.04e-05	0.000856	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	3.01e-05	0.000847	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3CA—coronary artery disease	2.98e-05	0.000841	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GCLC—coronary artery disease	2.97e-05	0.000837	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	2.55e-05	0.000718	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—AKT1—coronary artery disease	2.44e-05	0.000687	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GGT1—coronary artery disease	2.32e-05	0.000653	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CA5B—coronary artery disease	2.11e-05	0.000593	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	2.08e-05	0.000587	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	2.05e-05	0.000579	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	1.91e-05	0.000539	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	1.89e-05	0.000532	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CKMT1B—coronary artery disease	1.79e-05	0.000505	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPAP2B—coronary artery disease	1.46e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	1.46e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CKM—coronary artery disease	1.46e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PDK4—coronary artery disease	1.36e-05	0.000382	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SULT4A1—coronary artery disease	1.36e-05	0.000382	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PYGM—coronary artery disease	1.36e-05	0.000382	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CKMT2—coronary artery disease	1.36e-05	0.000382	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	1.36e-05	0.000382	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—POMC—coronary artery disease	1.35e-05	0.000381	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.21e-05	0.000341	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LDHA—coronary artery disease	1.21e-05	0.000341	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GYG1—coronary artery disease	1.21e-05	0.000341	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GK—coronary artery disease	1.21e-05	0.000341	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PFKM—coronary artery disease	1.21e-05	0.000341	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GATM—coronary artery disease	1.21e-05	0.000341	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AK1—coronary artery disease	1.15e-05	0.000325	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCH1—coronary artery disease	1.15e-05	0.000325	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPAT—coronary artery disease	1.11e-05	0.000312	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.11e-05	0.000312	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MDH2—coronary artery disease	1.11e-05	0.000312	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UGCG—coronary artery disease	1.11e-05	0.000312	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PGM1—coronary artery disease	1.06e-05	0.0003	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PYGB—coronary artery disease	1.03e-05	0.00029	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CKB—coronary artery disease	1.03e-05	0.00029	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTM2—coronary artery disease	9.67e-06	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PFKFB3—coronary artery disease	9.67e-06	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—COX5B—coronary artery disease	9.67e-06	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DLAT—coronary artery disease	9.67e-06	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLIN1—coronary artery disease	9.67e-06	0.000272	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SULT1E1—coronary artery disease	9.17e-06	0.000258	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HK2—coronary artery disease	8.75e-06	0.000246	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AKR1B1—coronary artery disease	8.75e-06	0.000246	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC27A1—coronary artery disease	8.38e-06	0.000236	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LCAT—coronary artery disease	8.22e-06	0.000232	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CPT1B—coronary artery disease	8.22e-06	0.000232	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA4—coronary artery disease	8.07e-06	0.000227	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCLM—coronary artery disease	7.79e-06	0.00022	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PDHA1—coronary artery disease	7.79e-06	0.00022	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP11B2—coronary artery disease	7.55e-06	0.000213	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—TXNRD1—coronary artery disease	7.55e-06	0.000213	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC22A3—coronary artery disease	7.44e-06	0.00021	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ARNTL—coronary artery disease	7.33e-06	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HADH—coronary artery disease	7.33e-06	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPX2—coronary artery disease	6.95e-06	0.000196	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA2—coronary artery disease	6.95e-06	0.000196	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	6.95e-06	0.000196	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HK1—coronary artery disease	6.86e-06	0.000193	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPX4—coronary artery disease	6.86e-06	0.000193	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ABCG5—coronary artery disease	6.86e-06	0.000193	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SULT1A1—coronary artery disease	6.86e-06	0.000193	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HADHA—coronary artery disease	6.78e-06	0.000191	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTA1—coronary artery disease	6.7e-06	0.000189	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPA—coronary artery disease	6.63e-06	0.000187	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLCB3—coronary artery disease	6.42e-06	0.000181	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA5—coronary artery disease	6.35e-06	0.000179	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—P4HB—coronary artery disease	6.23e-06	0.000176	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	6.12e-06	0.000172	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—VCAN—coronary artery disease	5.77e-06	0.000162	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.72e-06	0.000161	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DCN—coronary artery disease	5.55e-06	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.4e-06	0.000152	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HBA1—coronary artery disease	5.27e-06	0.000148	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LIPC—coronary artery disease	5.27e-06	0.000148	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.27e-06	0.000148	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.27e-06	0.000148	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOC3—coronary artery disease	5.23e-06	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LDLR—coronary artery disease	5.2e-06	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.14e-06	0.000145	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.14e-06	0.000145	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CETP—coronary artery disease	5.08e-06	0.000143	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCLC—coronary artery disease	5.08e-06	0.000143	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SDC1—coronary artery disease	5.02e-06	0.000142	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.75e-06	0.000134	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.75e-06	0.000134	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CTGF—coronary artery disease	4.64e-06	0.000131	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.59e-06	0.000129	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT2—coronary artery disease	4.59e-06	0.000129	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.22e-06	0.000119	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.09e-06	0.000115	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GGT1—coronary artery disease	3.97e-06	0.000112	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT1—coronary artery disease	3.97e-06	0.000112	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.56e-06	0.0001	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.53e-06	9.94e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.51e-06	9.9e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CAT—coronary artery disease	3.47e-06	9.77e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOB—coronary artery disease	3.37e-06	9.48e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.27e-06	9.22e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPL—coronary artery disease	3.21e-06	9.05e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPX1—coronary artery disease	3.13e-06	8.83e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CD36—coronary artery disease	3.05e-06	8.6e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.01e-06	8.49e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.89e-06	8.15e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AGT—coronary artery disease	2.75e-06	7.74e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOE—coronary artery disease	2.69e-06	7.59e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA1—coronary artery disease	2.66e-06	7.5e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARG—coronary artery disease	2.35e-06	6.61e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—POMC—coronary artery disease	2.31e-06	6.52e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALB—coronary artery disease	2.11e-06	5.94e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—NOS3—coronary artery disease	2.02e-06	5.68e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.85e-06	5.2e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.14e-06	3.2e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AKT1—coronary artery disease	9.28e-07	2.61e-05	CbGpPWpGaD
